company background image
002873 logo

Guiyang Xintian PharmaceuticalLtd SZSE:002873 Stock Report

Last Price

CN¥9.79

Market Cap

CN¥2.2b

7D

-10.5%

1Y

-19.0%

Updated

23 Dec, 2024

Data

Company Financials

Guiyang Xintian Pharmaceutical Co.,Ltd.

SZSE:002873 Stock Report

Market Cap: CN¥2.2b

002873 Stock Overview

Engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China. More details

002873 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Guiyang Xintian Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guiyang Xintian PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥9.79
52 Week HighCN¥14.33
52 Week LowCN¥7.49
Beta-0.17
1 Month Change-1.61%
3 Month Change21.16%
1 Year Change-19.02%
3 Year Change-29.17%
5 Year Change16.79%
Change since IPO23.05%

Recent News & Updates

Why Guiyang Xintian PharmaceuticalLtd's (SZSE:002873) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 04
Why Guiyang Xintian PharmaceuticalLtd's (SZSE:002873) Shaky Earnings Are Just The Beginning Of Its Problems

Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Oct 01
Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Recent updates

Why Guiyang Xintian PharmaceuticalLtd's (SZSE:002873) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 04
Why Guiyang Xintian PharmaceuticalLtd's (SZSE:002873) Shaky Earnings Are Just The Beginning Of Its Problems

Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Oct 01
Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jun 05
Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Apr 19
Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Mar 11
Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Shareholder Returns

002873CN PharmaceuticalsCN Market
7D-10.5%-1.9%-1.2%
1Y-19.0%-1.8%11.8%

Return vs Industry: 002873 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: 002873 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 002873's price volatile compared to industry and market?
002873 volatility
002873 Average Weekly Movement8.8%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002873 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002873's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19951,958Da Lun Dongwww.gyxtyy.com

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China. The company offers formulation products, which include hard capsules, granules, tablets, mixtures, syrups, liquors, dews, powders, suspensions, and gels.

Guiyang Xintian Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Guiyang Xintian PharmaceuticalLtd's earnings and revenue compare to its market cap?
002873 fundamental statistics
Market capCN¥2.20b
Earnings (TTM)CN¥54.16m
Revenue (TTM)CN¥839.16m

38.4x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002873 income statement (TTM)
RevenueCN¥839.16m
Cost of RevenueCN¥214.49m
Gross ProfitCN¥624.67m
Other ExpensesCN¥570.51m
EarningsCN¥54.16m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.25
Gross Margin74.44%
Net Profit Margin6.45%
Debt/Equity Ratio71.0%

How did 002873 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

30%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:48
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guiyang Xintian Pharmaceutical Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mengmeng HanPing An Securities Co. Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd